Skip to content

KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease : A 10-year Longitudinal Cohort Study of the Chronic Kidney Disease

KoreaN Cohort Study for Outcome in Patients With Chronic Kidney Disease

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01630486
Acronym
KNOW-CKD
Enrollment
2238
Registered
2012-06-28
Start date
2011-03-31
Completion date
2022-12-31
Last updated
2019-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

renal progression, mortality, complications, risk factors, role of biochemical parameters, genetic influence

Brief summary

The goals of the KNOW-CKD (KoreaN cohort study for Outcome in patients With Chronic Kidney Disease) study are 1) to establish a CKD cohort representing Korean CKD population for up to 10-year follow-up, and 2) to investigate the renal progression, mortality, complications, risk factors, role of biochemical parameters and the genetic influence. KNOW-CKD Research Group comprises nephrologists, pediatric nephrologists, epidemiologists and statisticians from eleven centers in Korea. KNOW-CKD will enroll 2,850 individuals with CKD stage from 1 to 5 between 2011 and 2015 and follow them up to 10 years. Dialyzed patients or those with allograft kidney are excluded. At enrollment and at pre-specified intervals, laboratory tests will be conducted on the kidney function, biochemical profiles, anemia, cardiovascular complication (echocardiography, coronary CT, arterial stiffness), and mineral bone disorder. A biobank is also established for the DNA, serum and urine at regular interval. Information on the medical history, health questionnaires, QoL will also be collected. Web-based case-report forms (CRF) is developed for the systemic management of the patient data.

Interventions

None listed

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Age: \>20 and \<75 yr, * CKD stage 1 through 5 * predialysis

Exclusion criteria

* Unable or unwilling to give consent * Previously received chronic dialysis * Previous any organ transplant * Heart failure * Known liver cirrhosis * past or current cancer * Pregnant women * Single kidney due to trauma or donation

Design outcomes

Primary

MeasureTime frame
overall mortality10 years

Secondary

MeasureTime frameDescription
cardiovascular event10 years
renal replacement therapy10 yearsdialysis or kidney transplantation
doubling of serum creatinine10 years

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 20, 2026